The U.S. Chamber of Commerce withdrew its lawsuit challenging the “transparency in coverage” rule that required insurers and employers to reveal unprecedented amounts of data about negotiated rates for health care services. The Chamber and the Pharmaceutical Care Management Association (PCMA) had filed twin lawsuits challenging the Trump-era rule’s provisions requiring the disclosure of negotiated rates with in-network providers, historical allowed amounts to out-of-network providers, and historical net prices for prescription drugs furnished by in-network providers, via “standardized, regularly updated machine-readable files” by Jan. 1, 2022. The Chamber’s decision to dismiss its lawsuit comes after the Biden administration issued guidance on Aug. 20 that postponed the drug-price disclosures indefinitely and delayed the requirement to reveal the other data in machine-readable files by six months. PCMA, in a statement sent to AIS Health following the issuance of the new guidance, stated that the trade group “is reviewing the status of our litigation on the Transparency in Coverage rule.”

Blue Cross and Blue Shield of North Carolina will offer members a type 2 diabetes prevention program called Eat Smart, Move More, Prevent Diabetes. The year-long program was developed and will be delivered by NC State University, and the Blues insurer said it is “reaching out to eligible members who have been diagnosed with prediabetes or who are at high risk of developing type 2 diabetes and inviting them to participate.” The insurer said a similar program in place since 2005 produced $972 in average annual savings per member.

Unlock the full version of this article by subscribing.

Log in | Learn More